 SAN DIEGO , Jan. 3, 2023 PRNewswire -- Halozyme Therapeutics, Inc. NASDAQ: HALO Halozyme today announced that Dr. Helen Torley, president and chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 at 3:45 p.m. 